Themes Market Research Reports

Subscribe to RSS Feed
  1. 04 May 2021  |  North America  |  Market Research

    The COVID-19 Pandemic and a Rising Focus on Women’s Untapped Healthcare Needs are Transforming the Global Femtech Solutions Industry

    The Healthcare Needs of the 3.90 Billion Global Female Population Creates New Growth Opportunities

    In an era of precision medicine and precision health, women deserve to receive gender-specific healthcare. The side-effects of the pandemic, like prolonged homestay induced by lockdowns, have disproportionately impacted women who have experienced a higher burden of household chores, increased anxiety and depression, etc., leading to a dramatic incr...

    $4,950.00
  2. 25 Jun 2019  |  Global  |  Technology Research

    Medical Device Innovations Furthering FemTech

    Disruptive Innovations Enabling Unique Solutions in Women’s Health

    FemTech is a technology terminology coined by the Danish entrepreneur Ida Tin, the founder of Clue, a popular fertility tracking digital solution. FemTech is short for “female technology”, an umbrella term that clubs together devices, software and solutions for the benefit of women. FemTech solutions addresses a whole host of health considerati...

    $4,950.00
  3. 30 Nov 2017  |  Europe  |  Market Research

    Growth Opportunities in European Prenatal Genetic Testing Market, Forecast to 2021

    Non-invasive Prenatal Testing (NIPT) Driven by the Adoption of Next Generation Sequencing (NGS) Techniques for Screening is Driving Market Growth

    Prenatal genetic tests are predominantly used to test disorders such as aneuploidies in chromosomes 21, 18, 13 and carrier screens. They are gaining momentum in EU due to enhanced assay outcomes through non-invasive methodologies using next generation sequencing (NGS) techniques, increasing number of women choosing to undergo pregnancy at an advanc...

    $3,000.00
  4. 21 Jul 2017  |  North America  |  Market Research

    Growth Opportunities in the US Prenatal Genetic Testing Market, Forecast to 2021

    Rising Maternal Age, Improved Screening Algorithms Catering to Healthcare Payer Requirements, and Exploration of New Business Models Will Drive Market

    Prenatal genetic tests, which are predominantly used to test disorders such as aneuploidies in chromosomes 21, 18, and 13, and carrier screens, are gaining momentum in the United States due to enhanced assay outcomes through non-invasive methodologies, increased popularity through social media channels, and the growing number of women choosing to u...

    $4,950.00